Nektar Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NKTR and other ETFs, options, and stocks.

About NKTR

Nektar Therapeutics is a research-based biopharmaceutical company which engages in discovering and developing medicines in areas of unmet medical need. Its research and development pipeline of new investigational drugs includes therapies for oncology, immunology and virology. 

CEO
Howard W. Robin
CEOHoward W. Robin
Employees
740
Employees740
Headquarters
San Francisco, California
HeadquartersSan Francisco, California
Founded
1990
Founded1990
Employees
740
Employees740

NKTR Key Statistics

Market cap
598.76M
Market cap598.76M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.81M
Average volume1.81M
High today
$3.36
High today$3.36
Low today
$3.05
Low today$3.05
Open price
$3.05
Open price$3.05
Volume
2.07M
Volume2.07M
52 Week high
$18.69
52 Week high$18.69
52 Week low
$2.96
52 Week low$2.96

Analyst ratings

70%

of 10 ratings
Buy
0%
Hold
70%
Sell
30%

NKTR Earnings

-$0.94
-$0.63
-$0.31
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3, After Hours
ActualExpected Nov 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.